Pre-Conference Day
Tuesday - 23 April, 2024
Morning Workshop with Roche
9am - 1pm
Predictive BMx Journey from Concept to Commercialization: Starting with the End in Mind
Join Roche for a morning of blended learning, with presentations, panel discussions, and group debate, covering key topics including:
- Commericialisation
- CDx Development - IVDR, Multi-Stage/Pan Tumor Approach
- Early BMx Discovery
Afternoon Thought Leadership Engager with Foundation Medicine
2pm - 4pm
Advancing Novel Biomarkers from Discovery through
Commercialization
Learn about innovative new biomarkers, like Foundation Medicine’s HRD signature and ctDNA tumor fraction, and how your essential diagnostics partner can support early biomarker discovery efforts through global clinical trial development and regulatory milestones
Expert speakers:
Colton Ballou, Associate Director Business Development, Foundation Medicine
Megan Townsend, Senior Manager, Foundation Medicine
Evening Thought Leadership Engager with Quest
5pm - 7pm
Join us for a hosted learning and networking Engager in partnership with Quest Diagnostics.
*Attendance subject to availability & approval